Trulieve CannabisTRLV -0.35%63 Operating Margin % is 12.36% as of Mar. 2026, which is 29% below its 10-year median of 17.52. GuruFocus rates TRLV with a GF Score™ of 63/100 and a GF Value™ of $6.03 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 955 Drug Manufacturers companies, Trulieve Cannabis ranks better than 63.46% on this metric.
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Trulieve Cannabis Operating Margin % Related Terms
Trulieve Cannabis Operating Margin % Historical Data
* Premium members only.
The historical data trend for Trulieve Cannabis's Operating Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Trulieve Cannabis's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Trulieve Cannabis Operating Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Trulieve Cannabis's Operating Margin % distribution charts can be found below:
* The bar in red indicates where Trulieve Cannabis's Operating Margin % falls into.
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
Trulieve Cannabis's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Trulieve Cannabis (TRLV) has a Operating Margin % of 12.36% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Trulieve Cannabis and its competitors. This is 29% below median its historical median of 17.52. Over the past decade, Trulieve Cannabis' Operating Margin % has ranged from 7.80 to 44.83. According to the industry distribution chart, Trulieve Cannabis ranks #349 out of 955 companies in the Drug Manufacturers industry, placing it in the top 36.5%.
Is Trulieve Cannabis' Operating Margin % too high?
Trulieve Cannabis' current Operating Margin % of 12.36% is 29% below median its 10-year median of 17.52. Over the past 10 years, this metric has ranged from a low of 7.80 to a high of 44.83. The Drug Manufacturers industry median Operating Margin % is 7.45. Trulieve Cannabis' value of 12.36% is 65.9% above this industry median. Based on the distribution chart, Trulieve Cannabis ranks #349 out of 955 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Trulieve Cannabis has a GF Score™ of 63/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Trulieve Cannabis' Operating Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Trulieve Cannabis ranks #349 out of 955 companies for Operating Margin %. This puts Trulieve Cannabis in the upper half of its industry. The industry median Operating Margin % is 7.45. Trulieve Cannabis' value of 12.36% is 65.9% above this benchmark. Historically, Trulieve Cannabis' own Operating Margin % has ranged from 7.80 to 44.83 over the past decade. While the company's 10-year median is 17.52 vs. the industry median of 7.45, Trulieve Cannabis has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Drug Manufacturers company?
The median Operating Margin % among Drug Manufacturers companies is 7.45, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Trulieve Cannabis's current Operating Margin % of 12.36% is 65.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Trulieve Cannabis and its competitors. For the Drug Manufacturers industry, the median Operating Margin % is 7.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Trulieve Cannabis's current Operating Margin % is 12.36%, which is 29% below median its own 10-year median of 17.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Trulieve Cannabis stock overvalued right now?
Based on GuruFocus' analysis, Trulieve Cannabis (TRLV) is currently considered Significantly Overvalued. The stock's GF Value™ is $6.03, compared to a current price of $8.50 — trading 41% above its estimated fair value. The current Operating Margin % is 12.36%, which is 29% below median its 10-year median of 17.52 and 65.9% above the Drug Manufacturers industry median of 7.45. Trulieve Cannabis' overall GF Score™ is 63/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Trulieve Cannabis (TRLV), the current Operating Margin % is 12.36% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Trulieve Cannabis (TRLV) Overvalued in 2026?
Based on GuruFocus' analysis, Trulieve Cannabis stock appears to be overvalued.
The current stock price of $8.50 is trading 41% above its estimated GF Value™ of $6.03.
GuruFocus considers Trulieve Cannabis to be Significantly Overvalued.
Key valuation signals for TRLV:
Operating Margin %: 12.36% (29% below median its 10-year median of 17.52)
GF Value™: $6.03 vs. price of $8.50 (41% above fair value)
Industry Position: 65.9% above the Drug Manufacturers median (#349 of 955)
No single metric tells the full story. See the TRLV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Trulieve Cannabis Corp is a vertically integrated cannabis company that grows, produces, and sells cannabis products. It has licenses to operate in Arizona, Colorado, Connecticut, Florida, Georgia, Maryland, Ohio, Pennsylvania, and West Virginia, where it sells medical cannabis products. In addition, the company sells cannabis products for adult use in Arizona, Colorado, Connecticut, Maryland, and Ohio. The firm's operations are substantially located in Florida and, to a lesser extent, in Arizona and Pennsylvania.
63GF Score
Get the complete analysis for TRLV
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TRLV has been successfully added to your 
